P. A. Campochiaro

PKC412--a protein kinase inhibitor with a broad therapeutic potential.

D Fabbro, Stephan Ruetz, Stephan Bodis et al. · PubMed · 2000 · 270 citations

Medicine, Oncology, Pharmacology +15

Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.

Stanley A. Vinores, Ayman Youssri, José D. Luna et al. · PubMed · 1997 · 237 citations · Full text

Medicine, Ophthalmology, Vision Science +15

Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.

Stanley A. Vinores, P. A. Campochiaro, Brian Conway · PubMed · 1990 · 162 citations

Medicine, Ophthalmology, Pathology +13

A Phase I Trial of an IV-Administered Vascular Endothelial Growth Factor Trap for Treatment in Patients with Choroidal Neovascularization due to Age-Related Macular Degeneration

Quang D. Nguyen, Sada H. Shah, Gulnar Hafiz et al. · Ophthalmology · 2006 · 153 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes

Y.-S. Chen, S. F. Hackett, C. Schoenfeld et al. · British Journal of Ophthalmology · 1997 · 106 citations · Full text

Medicine, Cell Biology, Ophthalmology +17